𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Opening Opportunities for New Drugs Against Neglected Diseases

✍ Scribed by Maria Paola Costi; Donatella Taramelli; Dolores González-Pacanowska

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
196 KB
Volume
3
Category
Article
ISSN
1860-7179

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Orphan drug legislation: lessons for neg
Orphan drug legislation: lessons for neglected tropical diseases
✍ Stefano Villa; Amelia Compagni; Michael R. Reich 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract In the last 20 years, orphan drug legislation (ODL) has been adopted in several countries around the world (USA, Japan, Australia, and the European Union) and has successfully promoted R&D investments to develop new pharmaceutical products for the treatment of rare diseases. Without the

Advance market commitments for vaccines
Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness
✍ Ernst R. Berndt; Rachel Glennerster; Michael R. Kremer; Jean Lee; Ruth Levine; G 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 1 views

## Abstract The G8 is considering committing to purchase vaccines against diseases concentrated in low‐income countries (if and when desirable vaccines are developed) as a way to spur research and development on vaccines for these diseases. Under such an ‘advance market commitment,’ one or more spo